Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: An EPCRC opioid guidelines project
- 27 June 2011
- journal article
- review article
- Published by SAGE Publications in Palliative Medicine
- Vol. 25 (5) , 578-596
Abstract
The European Palliative Care Research Collaboration is updating the EAPC recommendations on opioids in cancer pain management. A systematic literature search on Medline on the use of alternative routes for opioid application identified 242 papers, with 72 publications included in the final evaluation. Two or more alternative routes of opioid application were compared in 18 papers with a total of 674 patients. The best evidence base was available for the subcutaneous route. A comparison of subcutaneous and intravenous routes found no differences, confirming both routes as feasible, effective and safe. Efficacy and safety of the rectal route was comparable to the parenteral route. The side effect profile seemed to be very similar for the subcutaneous, intravenous, rectal or transdermal routes. Local side effects were reported for rectal application as well as for subcutaneous and transdermal administration. In conclusion, the systematic review found good evidence that subcutaneous administration of morphine or other opioids is an effective alternative for cancer patients if oral treatment is not possible. However, for a number of patients intravenous, rectal or transdermal therapy will offer a good alternative to the subcutaneous route. The review found no significant differences in efficacy or side effects between the alternative application routes.Keywords
This publication has 50 references indexed in Scilit:
- Efficacy and Safety of Transdermal Buprenorphine: A Randomized, Placebo-Controlled Trial in 289 Patients with Severe Cancer PainJournal of Pain and Symptom Management, 2008
- Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough painBritish Journal of Cancer, 2007
- Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian RegionBritish Journal of Clinical Pharmacology, 2006
- Care of the DyingJournal of Pain and Symptom Management, 2002
- A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioidsCancer, 2002
- Continuous Subcutaneous Infusion of Morphine vs. HydromorphoneJournal of Pain and Symptom Management, 1999
- Fentanyl by Continuous Subcutaneous Infusion for the Management of Cancer PainJournal of Pain and Symptom Management, 1998
- Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of lifeJournal of Pain and Symptom Management, 1997
- Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer painPain, 1995
- Management of terminal cancer pain in Sweden: a nationwide surveyPain, 1993